[Form 3] Freightos Ltd Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Freightos Ltd Chief Technology Officer Enric Alventosa Abril filed an initial Form 3 reporting his equity interests in the company. He directly holds ordinary shares, including amounts underlying restricted share units that vest between July 2023 and December 2027, plus several stock option grants exercisable at $4.17 and $8.44 per share with expirations ranging from 2031 to 2032.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Alventosa Abril Enric

(Last) (First) (Middle)

C/O FREIGHTOS LIMITED, PLANTA 10

AVDA. DIAGONAL, 211

(Street)

BARCELONA 08018

(City) (State) (Zip)

SPAIN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]

3a. Foreign Trading Symbol
[N/A]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares(1)	30,820	D
Ordinary shares(2)	35,480	D
Ordinary shares(3)	25,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options (right to buy)	04/01/2025	04/27/2031	Ordinary shares	35,181	$4.17	D
Stock options (right to buy)	01/01/2026	02/17/2032	Ordinary shares	58,048	$4.17	D
Stock options (right to buy)	(4)	11/02/2032	Ordinary shares	42,217	$8.44	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted by the Issuer to the Reporting Person that began vesting on July 15, 2023 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

2. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2024 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis such that all such RSUs will be vested by December 31, 2027.

3. The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.

4. The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney.

	/s/ Michael Oberlander, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)